2C-TFE

2C-TFE
Clinical data
Other names4-(2,2,2-Trifluoroethyl)-2,5-dimethoxyphenethylamine
Routes of
administration		Oral[1]
Drug classSerotonergic psychedelic; Hallucinogen
ATC code
  • None
Pharmacokinetic data
Duration of action12–24 hours[1]
Identifiers
  • 2-[2,5-dimethoxy-4-(2,2,2-trifluoroethyl)phenyl]ethan-1-amine
PubChem CID
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC12H16F3NO2
Molar mass263.260 g·mol−1
3D model (JSmol)
  • COC1=CC(=C(C=C1CCN)OC)CC(F)(F)F
  • InChI=1S/C12H16F3NO2/c1-17-10-6-9(7-12(13,14)15)11(18-2)5-8(10)3-4-16/h5-6H,3-4,7,16H2,1-2H3
  • Key:DVENUPQPPXYSLN-UHFFFAOYSA-N

2C-TFE, also known as 4-(2,2,2-trifluoroethyl)-2,5-dimethoxyphenethylamine, is a lesser-known psychedelic drug of the phenethylamine and 2C families related to 2C-E and 2C-TFM.[2][1] It was first synthesised by Daniel Trachsel, and is reportedly a potent psychedelic with an active dose in the 5 to 15 mg range orally, and a long duration of 12 to 24 hours.[2][1]: 769–771 

See also

References

  1. ^ a b c d Trachsel D, Lehmann D, Enzensperger C (2013). Phenethylamine: Von der Struktur zur Funktion. Nachtschatten Verlag AG. ISBN 978-3-03788-700-4.
  2. ^ a b Trachsel D (2012). "Fluorine in psychedelic phenethylamines". Drug Testing and Analysis. 4 (7–8): 577–590. doi:10.1002/dta.413. PMID 22374819.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.